Back to MRNA overview

MRNA Moderna PE ratio, current and historical analysis

The current PE ratio of MRNA can't be determined, as the TTM EPS of -$12.33 is negative. The last recorded PE ratio for Moderna was 39.19 in June 2023.

MRNA PE ratio history

How has MRNA's PE ratio performed in the past

The average historical PE ratio of Moderna for the last three years is 22.07. Over the past three years, MRNA's PE ratio was at its highest in the Mar 2021 quarter at 90.31, when the stock price was $130.95 and the EPS was $1.45. The lowest value was in the Sep 2022 quarter, when it reached 4.03 with a price of $118.25 and an EPS of $29.37.


Moderna PE ratio by year

Maximum annual increase: 0.84% in 2022

Year PE ratio Change
2023 N/A N/A
2022 8.45 0.84%
2021 8.38 N/A
2020 N/A N/A
2019 N/A N/A
2018 N/A N/A
2017 N/A N/A
2016 N/A N/A

MRNA average PE ratio chart

What is the average PE ratio of MRNA for the past years
3-year avg
5-year avg
10-year avg
15-year avg

MRNA PE vs peers

What is MRNA's PE ratio compared to its peers
Stock name PE ratio Market cap
JNJ Johnson & Johnson 11.66 $389.83B
NVS Novartis AG 14.53 $212.38B
MRK Merck & Co Inc 71.52 $328.03B
RGLS Regulus Therapeutics Inc N/A $29.53M
ARWR Arrowhead Pharmaceuticals Inc N/A $3.91B
ALNY Alnylam Pharmaceuticals Inc N/A $19.86B
MRNA Moderna Inc N/A $36.85B

Frequently asked questions

What is Moderna's PE ratio?

The current price to earnings ratio of MRNA can't be calculated, as its EPS of -$12.33 is negative.

What is the 3-year average PE ratio for Moderna (MRNA)?

The 3-year average PE ratio for MRNA stock is 22.07.

What is the 5-year average PE ratio for Moderna (MRNA)?

The 5-year average PE ratio for MRNA stock is 22.07.

What is the highest PE ratio for MRNA?

In the last three years, the Mar 2021 quarter recorded the highest quarterly PE ratio at 90.31.

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.